Telemedicine Alopecia Assessment: Highlighting Patients With Skin of Color

Britney N Wilson; Amy McMichael; Andrew Alexis; Oma Agbai; Nada Elbuluk; Valerie Callender; Cheryl M Burgess; Susan C Taylor

doi:10.12788/cutis.0419

Telemedicine Alopecia Assessment: Highlighting Patients With Skin of Color

Cutis. 2022 Jan;109(1):40-42. doi: 10.12788/cutis.0419.

Authors

Britney N Wilson¹, Amy McMichael¹, Andrew Alexis¹, Oma Agbai¹, Nada Elbuluk¹, Valerie Callender¹, Cheryl M Burgess¹, Susan C Taylor¹

Affiliation

¹ Ms. Wilson is from Rutgers New Jersey Medical School, Newark, New Jersey. Dr. McMichael is from the Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Dr. Alexis is from the Department of Dermatology, Weill Cornell Medicine, New York, New York. Dr. Agbai is from the Department of Dermatology, UC Davis School of Medicine, Sacramento, California. Dr. Elbuluk is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Callender is from private practice, Glenn Dale, Maryland. Dr. Burgess is from Howard University College of Medicine, Washington, DC, and private practice, Glenn Dale. Dr. Taylor is from the Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 35180055
DOI: 10.12788/cutis.0419

Abstract

Alopecia has been one of the more common concerns reported at teledermatology (TD) visits during the COVID-19 pandemic. In light of the growing use of TD, a team of experts were consulted to develop workflows for virtual hair and scalp examinations, with particular consideration for skin of color patients.

MeSH terms

Alopecia / diagnosis
COVID-19*
Humans
Pandemics
SARS-CoV-2
Skin Pigmentation
Telemedicine*